News
Vital funding established for Evonetix projects
Evonetix – a company which focuses on semiconductor technology and DNA synthesis – has revealed the completion of a pivotal $24m financing round.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Evonetix – a company which focuses on semiconductor technology and DNA synthesis – has revealed the completion of a pivotal $24m financing round.